Impax Laboratories (IPXL) Misses Q3 EPS by 2c
Get Alerts IPXL Hot Sheet
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q3 EPS of $0.37, $0.02 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $228 million versus the consensus estimate of $234.87 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Towne Bank (TOWN) Reports In-Line Q1 EPS
- Towne Bank (TOWN) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!